Published: 2016-12-16

Endothelial nitric oxide synthase gene glu298asp polymorphism in preterm neonates with respiratory distress syndrome

Mona Abdel-Wahab Albeshery, Omima Mohamed Abdel-Haie, Nesrein Salama Ramadan, Shuzan Ali Mohammed


 Background: Neonatal respiratory distress syndrome (RDS) is a multifactorial disease of preterm influenced by many factors including gene polymorphism. The aim of the present study was to determine the effect of endothelial nitric oxide synthase gene glu298asp polymorphism (rs1799983) in developing and grading of RDS in preterm neonates.

Methods: This study was performed on 65 preterm neonates; 40 with RDS and 25 healthy controls. Genotyping of endothelial nitric oxide synthase gene glu298asp polymorphism was performed by restriction fragment length polymorphism.

Results: There were statistical significant increases in TT, (GT+TT) genotypes and T allele frequencies of rs1799983 among RDS neonates compared to controls. As groups were categorized by gestational age; TT genotype and T allele frequencies were statistically significantly increased in 33-35weeks RDS neonates compared to controls. TT genotype in RDS was associated with RDS grade III, mechanical ventilation need, and increased mortality. TT genotype, T allele, gestational age (<28-32weeks) and birth weight (<1500grams) were predictor factors for RDS in binary logistic regression analysis.

Conclusions: eNOS glu298asp polymorphism could be implicated in RDS pathophysiology and may affect the disease severity and outcome. TT, GT+TT Genotypes and T allele might be predisposing risk factors for RDS in preterms. TT genotype and T allele might be of the predictors of neonatal RDS.


Endothelial nitric oxide synthase, Polymorphism, RDS, RFLP, rs1799983

Full Text:



Hermansen CL, Lorah KN. Respiratory distress in the newborn. Am Fam Physician. 2007;76:987.

Shen CL, Zhang Q, Meyer-Hudson J, Cole FS, Wambach JA. Genetic factors contribute to risk for neonatal respiratory distress syndrome among moderately preterm, late preterm, and term infants. J Pediatr. 2016;172:69.

Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109.

Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 1995;9:1319.

Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993;268:17478.

Wattanapitayakul SK, Mihm MJ, Young AP, Bauer JA. Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism. Trends Pharmacol Sci. 2001;22:361.

Wilfinger WW, Mackey K, Chomczynski P. Effect of pH and ionic strength on the spectrophotometric assessment of nucleic acid purity. Biotechniques. 1997;22:474.

Emam WA, Zidan HE, Abdulhalim BE, Dabour SA, Ghali MA, Kamal AT. Endothelial nitric oxide synthase polymorphisms and susceptibility to high-tension primary open-angle glaucoma in an Egyptian cohort. Molecular Vision. 2014;20:804.

Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. Endothelial nitric oxide synthase: From biochemistry and gene structure to clinical implications of NOS3 polymorphisms. Gene. 2016;575:584.

Yoo SD, Park JS, Yun DH, Kim HS, Kim SK, Kim DH, et al. Polymorphism of Nitric Oxide Synthase 1 Affects the Clinical Phenotypes of Ischemic Stroke in Korean Population. Ann Rehabil Med. 2016;40:102.

Han RN, Babaei S, Robb M, Lee T, Ridsdale R, Ackerley C, et al. Defective lung vascular development and fatal respiratory distress in endothelial NO synthase-deficient mice: a model of alveolar capillary dysplasia? Circ Res. 2004;94:1115.

Poggi C, Giusti B, Gozzini E, Sereni A, Romagnuolo I, Kura A, et al. Genetic contributions to the development of complications in preterm newborns. PLoS One. 2015;10:e0131741.

Shen W, Du J, Wang B and Zeng Q. Analysis of nitric oxide synthase gene polymorphisms in neonatal respiratory distress syndrome among the Chinese Han population. Ital J Pediatr. 2014;40:27.

Sivasli E, Babaoglu M, Yasar U, Yurdakök M, Bozkurt A, Korkmaz A, et al. Association between the Glu298Asp and T(−786)C polymorphisms of the endothelial nitric oxide synthase gene and respiratory distress in preterm neonates. Turk J Pediatr. 2010;52:145.

Drummond GR, Cai H, Davis ME, Ramasamy S, Harrison DG. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res. 2000;86:347.

Yanar K, Çakatay U, Aydın S, Verim A, Atukeren P, Özkan NE, et al. Relation between Endothelial Nitric Oxide Synthase Genotypes and Oxidative Stress Markers in Larynx Cancer. Oxid Med Cell Longev. 2016;4985063.

Wang XL, Sim AS, Wang MX, Murrell GA, Trudinger B, Wang J. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett. 2000;471:45.

Hong CC, Ambrosone CB, Ahn J, Choi JY, McCullough ML, Stevens VL, et al. Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:1784.

Endo A, Shimada M, Ayusawa M, Minato M, Takada M, Takahashi S, et al. Nitric oxide and endothelin 1 during postnatal life. Biol Neonate. 1996;70:15.

Negi R, Pande D, Karki K, Kumar A, Khanna RS, Khanna HD, et al. A novel approach to study oxidative stress in neonatal respiratory distress syndrome. BBA Clin. 2015;3:65.

Demirçubuk GA, Coskun Y, Arslan A and Sivaslı E. Endothelial NOS Gene Glu298Asp Polymorphism in Preterm Neonates with Respiratory Distress Syndrome Pediatric Pulmonology. 2013;48:976.

McNamara DM, Holubkov R, Postava L, Ramani R, Janosko K, Mathier M, et al. Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure. Circulation. 2003;107:1598.